Document is current
Any future updates will be listed below
-
Authors
Degeling, Koen https://orcid.org/0000-0001-7487-2491
Vu, Martin https://orcid.org/0000-0001-5918-1692
Koffijberg, Hendrik https://orcid.org/0000-0002-1753-0652
Wong, Hui-Li https://orcid.org/0000-0003-3803-2107
Koopman, Miriam https://orcid.org/0000-0003-1550-1978
Gibbs, Peter https://orcid.org/0000-0003-1423-4484
IJzerman, Maarten https://orcid.org/0000-0001-5788-5805
- License Information
-
More Information
Article History
First Online: 22 April 2020
Compliance with Ethical Standards
:
: No funding was received for performing this study.
: Authors KD, HK, MK and MIJ acknowledge authorship on several publications that were included in the analysis. MK is advisor to The Netherlands Organisation for Health Research and Development, a member of the scientific board of the Dutch Cancer Society (KWF), chair of the Dutch Colorectal Cancer Group (DCCG), principal investigator (PI) for PLCRC (Dutch national observational cohort study), involved in several clinical trials in CRC as PI or co-investigator and declares unrestricted institutional grants from Amgen, Bayer, BMS, Merck-Serono, Nordic Farma, Roche, Servier, Sirtex and Sanofi-Aventis.
